Oral Topotecan

DRUG2 trials

Sponsors

Accelerated Community Oncology Research Network, Vector Oncology

Conditions

Gynecologic TumorsTumors

Phase 1

Oral Topotecan to Treat Recurrent or Persistent Solid Tumors

CompletedNCT00382733

Accelerated Community Oncology Research NetworkTumors

Start: 2006-11-30End: 2011-03-31Updated: 2013-07-22

Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors

CompletedNCT00800345

Vector OncologyGynecologic Tumors

Start: 2009-04-30End: 2015-09-30Updated: 2017-03-28